GRACE DARNELL: Open Payments
NPI 1689164477 · GOSHEN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$531 in 15 payments from 10 companies in 2025. Trend: 2023 $312 · 2024 $807 · 2025 $531
Food & beverage: $531
| Company | Payments | Amount |
|---|---|---|
| Tempus AI, Inc | 3 | $158 |
| GlaxoSmithKline, LLC. | 1 | $84 |
| AstraZeneca Pharmaceuticals LP | 1 | $77 |
| E.R. Squibb & Sons, L.L.C. | 2 | $63 |
| Genmab U.S., Inc. | 2 | $41 |
| Merck Sharp & Dohme LLC | 2 | $32 |
| PharmaEssentia USA Corporation | 1 | $22 |
| KYOWA KIRIN, INC. | 1 | $20 |
| JAZZ PHARMACEUTICALS INC. | 1 | $18 |
| BIOPROTECT MEDICAL, INC. | 1 | $16 |
Products named: XT CDX, JEMPERLI, LYNPARZA, OPDIVO, Tivdak, KEYTRUDA, BESREMI, POTELIGEO.
Industry payments across IN — which companies pay providers there.
